Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chondrocalcinosis | 22 | 2024 | 84 | 10.810 |
Why?
|
Calcium Pyrophosphate | 18 | 2024 | 55 | 4.050 |
Why?
|
Lupus Erythematosus, Systemic | 22 | 2023 | 2159 | 3.120 |
Why?
|
Arthritis, Rheumatoid | 25 | 2023 | 3733 | 2.520 |
Why?
|
Giant Cell Arteritis | 5 | 2021 | 302 | 2.220 |
Why?
|
Gout | 8 | 2024 | 620 | 2.150 |
Why?
|
Calcinosis | 9 | 2023 | 1479 | 1.970 |
Why?
|
Antirheumatic Agents | 11 | 2023 | 1365 | 1.730 |
Why?
|
Rheumatology | 10 | 2023 | 602 | 1.390 |
Why?
|
Uric Acid | 6 | 2024 | 809 | 1.090 |
Why?
|
Osteoarthritis | 3 | 2023 | 1051 | 1.050 |
Why?
|
Gout Suppressants | 2 | 2024 | 176 | 0.860 |
Why?
|
Terminology as Topic | 3 | 2019 | 1534 | 0.840 |
Why?
|
Allopurinol | 1 | 2024 | 203 | 0.830 |
Why?
|
Enterobacteriaceae Infections | 2 | 2021 | 189 | 0.700 |
Why?
|
Triangular Fibrocartilage | 1 | 2020 | 27 | 0.670 |
Why?
|
Antibodies, Antinuclear | 8 | 2024 | 340 | 0.610 |
Why?
|
Seafood | 2 | 2019 | 395 | 0.590 |
Why?
|
Coronavirus | 1 | 2020 | 155 | 0.590 |
Why?
|
Menisci, Tibial | 1 | 2020 | 266 | 0.570 |
Why?
|
Pelvic Bones | 1 | 2019 | 274 | 0.540 |
Why?
|
Ultrasonography | 2 | 2020 | 5993 | 0.540 |
Why?
|
Osteoporosis | 6 | 2023 | 1582 | 0.530 |
Why?
|
Fractures, Bone | 3 | 2024 | 2041 | 0.520 |
Why?
|
Humeral Fractures | 1 | 2019 | 283 | 0.520 |
Why?
|
Candidemia | 1 | 2016 | 46 | 0.510 |
Why?
|
Data Mining | 1 | 2021 | 562 | 0.510 |
Why?
|
Paraneoplastic Syndromes | 1 | 2017 | 156 | 0.500 |
Why?
|
Pressure Ulcer | 1 | 2017 | 155 | 0.500 |
Why?
|
Lupus Nephritis | 2 | 2019 | 320 | 0.500 |
Why?
|
Hyperuricemia | 4 | 2024 | 221 | 0.500 |
Why?
|
Carrier State | 1 | 2019 | 529 | 0.480 |
Why?
|
Wound Infection | 1 | 2017 | 244 | 0.470 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2015 | 61 | 0.460 |
Why?
|
Spondylarthritis | 3 | 2020 | 62 | 0.460 |
Why?
|
Humans | 118 | 2024 | 765968 | 0.450 |
Why?
|
Middle Aged | 59 | 2024 | 223009 | 0.430 |
Why?
|
Pregnancy Complications | 3 | 2017 | 2975 | 0.430 |
Why?
|
Rheumatic Diseases | 4 | 2021 | 622 | 0.430 |
Why?
|
Nurses | 8 | 2023 | 2505 | 0.420 |
Why?
|
Female | 77 | 2024 | 396112 | 0.410 |
Why?
|
Diet | 5 | 2019 | 8086 | 0.410 |
Why?
|
Antifungal Agents | 2 | 2021 | 769 | 0.400 |
Why?
|
Natural Language Processing | 1 | 2021 | 1203 | 0.380 |
Why?
|
Incidence | 20 | 2024 | 21480 | 0.380 |
Why?
|
Risk Factors | 33 | 2024 | 74840 | 0.370 |
Why?
|
Wrist Joint | 3 | 2024 | 264 | 0.370 |
Why?
|
Hip Fractures | 1 | 2019 | 997 | 0.360 |
Why?
|
Consensus | 5 | 2022 | 3202 | 0.350 |
Why?
|
Aged | 38 | 2024 | 171117 | 0.350 |
Why?
|
Bone Density Conservation Agents | 4 | 2023 | 791 | 0.340 |
Why?
|
Male | 52 | 2024 | 363698 | 0.340 |
Why?
|
Smoking | 9 | 2021 | 9081 | 0.330 |
Why?
|
Acute Coronary Syndrome | 1 | 2022 | 2184 | 0.330 |
Why?
|
Decision Support Techniques | 2 | 2019 | 2003 | 0.330 |
Why?
|
Spinal Cord Injuries | 1 | 2017 | 927 | 0.320 |
Why?
|
Temporal Arteries | 2 | 2021 | 154 | 0.320 |
Why?
|
Hepatitis B Vaccines | 2 | 2008 | 178 | 0.320 |
Why?
|
Italy | 7 | 2020 | 854 | 0.320 |
Why?
|
Prospective Studies | 26 | 2023 | 54802 | 0.310 |
Why?
|
Prediabetic State | 2 | 2024 | 548 | 0.310 |
Why?
|
Veterans | 1 | 2022 | 2664 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3100 | 0.310 |
Why?
|
Body Mass Index | 8 | 2021 | 13039 | 0.300 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3223 | 0.300 |
Why?
|
Severity of Illness Index | 10 | 2020 | 15880 | 0.300 |
Why?
|
Synovial Fluid | 2 | 2020 | 385 | 0.290 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2010 | 316 | 0.290 |
Why?
|
Electronic Health Records | 3 | 2022 | 4873 | 0.290 |
Why?
|
Prednisone | 2 | 2023 | 1565 | 0.280 |
Why?
|
Diet Surveys | 4 | 2021 | 1159 | 0.280 |
Why?
|
Cross Infection | 1 | 2016 | 1427 | 0.280 |
Why?
|
Myelodysplastic Syndromes | 1 | 2017 | 1404 | 0.280 |
Why?
|
Weight Gain | 1 | 2017 | 2355 | 0.270 |
Why?
|
Nutritive Value | 2 | 2021 | 351 | 0.270 |
Why?
|
Diphosphonates | 3 | 2023 | 625 | 0.270 |
Why?
|
Contraception | 2 | 2020 | 361 | 0.260 |
Why?
|
Anti-Bacterial Agents | 6 | 2021 | 7478 | 0.260 |
Why?
|
Bone Density | 4 | 2020 | 3491 | 0.260 |
Why?
|
Delphi Technique | 3 | 2019 | 893 | 0.260 |
Why?
|
Case-Control Studies | 8 | 2024 | 22223 | 0.260 |
Why?
|
Hydroxychloroquine | 4 | 2020 | 431 | 0.250 |
Why?
|
Pandemics | 5 | 2021 | 8703 | 0.250 |
Why?
|
Proportional Hazards Models | 8 | 2024 | 12509 | 0.250 |
Why?
|
Feeding Behavior | 1 | 2017 | 3212 | 0.250 |
Why?
|
Adult | 43 | 2024 | 223044 | 0.240 |
Why?
|
Obesity | 5 | 2020 | 13076 | 0.240 |
Why?
|
Pregnancy Outcome | 1 | 2016 | 2966 | 0.240 |
Why?
|
Propensity Score | 4 | 2024 | 1968 | 0.240 |
Why?
|
Prisons | 1 | 2007 | 178 | 0.230 |
Why?
|
Knee Joint | 3 | 2023 | 1656 | 0.230 |
Why?
|
Aged, 80 and over | 12 | 2024 | 59489 | 0.230 |
Why?
|
Methotrexate | 2 | 2022 | 1722 | 0.230 |
Why?
|
Socialism | 1 | 2003 | 1 | 0.230 |
Why?
|
Staphylococcal Infections | 3 | 2021 | 1393 | 0.230 |
Why?
|
Immunization Programs | 1 | 2007 | 267 | 0.220 |
Why?
|
Retrospective Studies | 19 | 2024 | 81514 | 0.220 |
Why?
|
Musculoskeletal Diseases | 2 | 2020 | 598 | 0.220 |
Why?
|
Papillomavirus Vaccines | 1 | 2010 | 496 | 0.220 |
Why?
|
Cohort Studies | 13 | 2024 | 41649 | 0.220 |
Why?
|
Acute Disease | 3 | 2024 | 7232 | 0.210 |
Why?
|
Cross-Sectional Studies | 10 | 2024 | 26318 | 0.210 |
Why?
|
Prisoners | 1 | 2007 | 316 | 0.210 |
Why?
|
Dietary Supplements | 1 | 2016 | 3425 | 0.210 |
Why?
|
Social Medicine | 1 | 2003 | 63 | 0.210 |
Why?
|
International Classification of Diseases | 2 | 2019 | 935 | 0.210 |
Why?
|
Reproducibility of Results | 8 | 2023 | 20124 | 0.200 |
Why?
|
Lymphocytes | 1 | 2010 | 2599 | 0.200 |
Why?
|
Glucocorticoids | 2 | 2024 | 2132 | 0.200 |
Why?
|
Radiography | 3 | 2023 | 6919 | 0.200 |
Why?
|
Patient Dropouts | 1 | 2024 | 410 | 0.200 |
Why?
|
United States | 22 | 2023 | 72903 | 0.200 |
Why?
|
Teicoplanin | 1 | 2021 | 27 | 0.190 |
Why?
|
Respiratory Insufficiency | 2 | 2020 | 1240 | 0.190 |
Why?
|
Longitudinal Studies | 7 | 2024 | 14751 | 0.190 |
Why?
|
Myocardial Infarction | 1 | 2022 | 11499 | 0.190 |
Why?
|
Multivariate Analysis | 6 | 2020 | 12056 | 0.190 |
Why?
|
Stem Cell Transplantation | 1 | 2010 | 1602 | 0.190 |
Why?
|
Adrenal Cortex Hormones | 3 | 2020 | 1880 | 0.190 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15652 | 0.190 |
Why?
|
Time Factors | 13 | 2024 | 40065 | 0.180 |
Why?
|
Complement System Proteins | 3 | 2019 | 715 | 0.180 |
Why?
|
Logistic Models | 6 | 2024 | 13266 | 0.180 |
Why?
|
Stroke | 1 | 2022 | 9747 | 0.170 |
Why?
|
Axillary Artery | 1 | 2020 | 48 | 0.170 |
Why?
|
Subclavian Artery | 1 | 2021 | 136 | 0.170 |
Why?
|
Hypertension | 1 | 2020 | 8626 | 0.170 |
Why?
|
Autoantibodies | 3 | 2024 | 2113 | 0.170 |
Why?
|
Acinetobacter baumannii | 1 | 2021 | 125 | 0.170 |
Why?
|
Aortitis | 1 | 2020 | 76 | 0.170 |
Why?
|
Sensitivity and Specificity | 6 | 2021 | 14652 | 0.170 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2021 | 235 | 0.170 |
Why?
|
Autoimmune Diseases | 2 | 2024 | 2226 | 0.160 |
Why?
|
Enterobacteriaceae | 1 | 2021 | 161 | 0.160 |
Why?
|
Women's Health | 2 | 2019 | 2084 | 0.160 |
Why?
|
Serologic Tests | 2 | 2019 | 382 | 0.160 |
Why?
|
Immunosuppressive Agents | 2 | 2022 | 4209 | 0.160 |
Why?
|
Alcohol Drinking | 2 | 2024 | 4040 | 0.160 |
Why?
|
Aortography | 1 | 2020 | 414 | 0.160 |
Why?
|
Body Image | 1 | 2003 | 644 | 0.150 |
Why?
|
Algorithms | 2 | 2022 | 14071 | 0.150 |
Why?
|
Prognosis | 8 | 2020 | 29922 | 0.150 |
Why?
|
Antibody Formation | 1 | 2023 | 1391 | 0.150 |
Why?
|
Diet Records | 1 | 2019 | 425 | 0.150 |
Why?
|
Drug Monitoring | 2 | 2021 | 962 | 0.150 |
Why?
|
Spondylitis, Ankylosing | 1 | 2019 | 157 | 0.150 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2020 | 239 | 0.140 |
Why?
|
Mycoses | 1 | 2021 | 389 | 0.140 |
Why?
|
Proteus Infections | 1 | 2017 | 10 | 0.140 |
Why?
|
Europe | 3 | 2020 | 3423 | 0.140 |
Why?
|
Teriparatide | 1 | 2019 | 225 | 0.140 |
Why?
|
Proteus mirabilis | 1 | 2017 | 24 | 0.140 |
Why?
|
Maryland | 1 | 2018 | 278 | 0.140 |
Why?
|
Osteomyelitis | 1 | 2021 | 408 | 0.140 |
Why?
|
Arthritis | 2 | 2024 | 677 | 0.140 |
Why?
|
Obesity, Abdominal | 1 | 2020 | 369 | 0.140 |
Why?
|
Academic Medical Centers | 3 | 2019 | 2780 | 0.140 |
Why?
|
Proton Pump Inhibitors | 1 | 2022 | 553 | 0.140 |
Why?
|
Risk Reduction Behavior | 2 | 2021 | 1123 | 0.140 |
Why?
|
Immunity, Cellular | 1 | 2023 | 1555 | 0.140 |
Why?
|
Politics | 1 | 2003 | 822 | 0.140 |
Why?
|
Metformin | 1 | 2024 | 904 | 0.130 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 714 | 0.130 |
Why?
|
Professional Practice | 1 | 2019 | 313 | 0.130 |
Why?
|
Sjogren's Syndrome | 1 | 2018 | 239 | 0.130 |
Why?
|
Wrist Injuries | 1 | 2019 | 215 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20659 | 0.130 |
Why?
|
Smoking Cessation | 2 | 2019 | 2084 | 0.130 |
Why?
|
Hospital Mortality | 3 | 2020 | 5343 | 0.130 |
Why?
|
Absorptiometry, Photon | 2 | 2019 | 1707 | 0.130 |
Why?
|
Models, Statistical | 2 | 2022 | 5089 | 0.130 |
Why?
|
Length of Stay | 3 | 2020 | 6485 | 0.130 |
Why?
|
Diagnostic Self Evaluation | 1 | 2017 | 228 | 0.130 |
Why?
|
Aortic Aneurysm | 1 | 2020 | 623 | 0.130 |
Why?
|
Renin-Angiotensin System | 1 | 2020 | 737 | 0.120 |
Why?
|
Pharmacoepidemiology | 1 | 2019 | 351 | 0.120 |
Why?
|
Cooking | 1 | 2018 | 327 | 0.120 |
Why?
|
Withholding Treatment | 1 | 2019 | 621 | 0.120 |
Why?
|
International Cooperation | 2 | 2019 | 1432 | 0.120 |
Why?
|
Research Design | 2 | 2022 | 6209 | 0.120 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2017 | 366 | 0.110 |
Why?
|
Debridement | 1 | 2017 | 495 | 0.110 |
Why?
|
Dengue | 1 | 2017 | 257 | 0.110 |
Why?
|
Hepatitis B virus | 1 | 2017 | 530 | 0.110 |
Why?
|
Hepatitis B | 2 | 2017 | 707 | 0.110 |
Why?
|
Hepatitis B, Chronic | 1 | 2018 | 412 | 0.110 |
Why?
|
Azathioprine | 1 | 2015 | 350 | 0.110 |
Why?
|
Metabolome | 1 | 2020 | 1005 | 0.110 |
Why?
|
Biological Products | 2 | 2019 | 942 | 0.110 |
Why?
|
Head | 1 | 2019 | 925 | 0.110 |
Why?
|
Candida albicans | 1 | 2016 | 377 | 0.110 |
Why?
|
Bacteremia | 1 | 2020 | 989 | 0.100 |
Why?
|
Stillbirth | 1 | 2016 | 381 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 1008 | 0.100 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2017 | 618 | 0.100 |
Why?
|
Comorbidity | 4 | 2020 | 10563 | 0.100 |
Why?
|
Cartilage, Articular | 1 | 2020 | 1089 | 0.100 |
Why?
|
Inflammation Mediators | 2 | 2019 | 1884 | 0.100 |
Why?
|
Pseudomonas Infections | 1 | 2017 | 622 | 0.100 |
Why?
|
Child Abuse | 1 | 2021 | 1090 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3110 | 0.100 |
Why?
|
Vaccination | 2 | 2023 | 3426 | 0.090 |
Why?
|
Infection Control | 1 | 2019 | 983 | 0.090 |
Why?
|
Flow Cytometry | 1 | 2022 | 5881 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3211 | 0.090 |
Why?
|
Life Style | 2 | 2021 | 3926 | 0.090 |
Why?
|
Abortion, Spontaneous | 1 | 2016 | 536 | 0.090 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4528 | 0.090 |
Why?
|
Quality Indicators, Health Care | 1 | 2021 | 1806 | 0.090 |
Why?
|
C-Reactive Protein | 2 | 2024 | 3850 | 0.090 |
Why?
|
Health Surveys | 2 | 2019 | 4056 | 0.090 |
Why?
|
Neoplasms | 1 | 2019 | 22340 | 0.090 |
Why?
|
Societies, Medical | 2 | 2019 | 3956 | 0.090 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15398 | 0.090 |
Why?
|
Body Weight | 2 | 2017 | 4622 | 0.090 |
Why?
|
Epitopes | 1 | 2016 | 2523 | 0.080 |
Why?
|
Organizational Innovation | 1 | 2013 | 541 | 0.080 |
Why?
|
Influenza, Human | 1 | 2020 | 1539 | 0.080 |
Why?
|
Phenotype | 2 | 2024 | 16721 | 0.080 |
Why?
|
Internal Medicine | 1 | 2016 | 1064 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2021 | 2412 | 0.080 |
Why?
|
Young Adult | 8 | 2021 | 59889 | 0.080 |
Why?
|
Chronic Disease | 2 | 2024 | 9347 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2020 | 12437 | 0.080 |
Why?
|
Medication Adherence | 1 | 2020 | 2192 | 0.070 |
Why?
|
Risk Assessment | 8 | 2021 | 24282 | 0.070 |
Why?
|
Lymphocyte Count | 1 | 2010 | 790 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2023 | 12768 | 0.070 |
Why?
|
Pregnancy | 5 | 2020 | 30260 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2268 | 0.070 |
Why?
|
Sex Factors | 3 | 2021 | 10603 | 0.070 |
Why?
|
Poverty | 1 | 2019 | 2714 | 0.070 |
Why?
|
Hospitals | 2 | 2020 | 3888 | 0.070 |
Why?
|
Femur Neck | 2 | 2019 | 316 | 0.070 |
Why?
|
Syndrome | 2 | 2023 | 3271 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2606 | 0.070 |
Why?
|
Treatment Outcome | 7 | 2021 | 65188 | 0.070 |
Why?
|
Pre-Eclampsia | 1 | 2016 | 1261 | 0.070 |
Why?
|
Taiwan | 2 | 2017 | 521 | 0.070 |
Why?
|
Health Behavior | 1 | 2017 | 2650 | 0.060 |
Why?
|
Rhode Island | 1 | 2007 | 351 | 0.060 |
Why?
|
Exercise | 2 | 2021 | 5937 | 0.060 |
Why?
|
Medicaid | 1 | 2019 | 2833 | 0.060 |
Why?
|
Cause of Death | 2 | 2021 | 3708 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10383 | 0.060 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 705 | 0.060 |
Why?
|
Biopsy | 1 | 2017 | 6763 | 0.060 |
Why?
|
Registries | 2 | 2020 | 8297 | 0.060 |
Why?
|
Brazil | 2 | 2020 | 1248 | 0.060 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2012 | 1354 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9338 | 0.060 |
Why?
|
Public Health Practice | 1 | 2007 | 219 | 0.060 |
Why?
|
Beer | 1 | 2024 | 134 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39193 | 0.060 |
Why?
|
State Government | 1 | 2007 | 388 | 0.050 |
Why?
|
Prevalence | 2 | 2018 | 15842 | 0.050 |
Why?
|
Medicare | 1 | 2021 | 6823 | 0.050 |
Why?
|
Osteoporotic Fractures | 2 | 2019 | 415 | 0.050 |
Why?
|
Leadership | 1 | 2013 | 1392 | 0.050 |
Why?
|
Body Constitution | 1 | 2003 | 272 | 0.050 |
Why?
|
Substance Abuse, Intravenous | 1 | 2008 | 531 | 0.050 |
Why?
|
Social Change | 1 | 2003 | 152 | 0.050 |
Why?
|
Chile | 1 | 2003 | 258 | 0.050 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3247 | 0.050 |
Why?
|
Survival Analysis | 3 | 2020 | 10070 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4850 | 0.050 |
Why?
|
Control Groups | 1 | 2022 | 106 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3835 | 0.050 |
Why?
|
Connective Tissue Diseases | 1 | 2024 | 284 | 0.050 |
Why?
|
Transplantation, Homologous | 1 | 2010 | 4860 | 0.050 |
Why?
|
Fabaceae | 1 | 2021 | 103 | 0.050 |
Why?
|
Diphosphates | 1 | 2021 | 91 | 0.050 |
Why?
|
Histamine H2 Antagonists | 1 | 2022 | 168 | 0.050 |
Why?
|
Putrescine | 1 | 2020 | 42 | 0.050 |
Why?
|
Butyric Acid | 1 | 2020 | 51 | 0.040 |
Why?
|
Spermidine | 1 | 2020 | 63 | 0.040 |
Why?
|
Philippines | 1 | 2020 | 95 | 0.040 |
Why?
|
Sexually Transmitted Diseases | 1 | 2007 | 667 | 0.040 |
Why?
|
Influenza B virus | 1 | 2020 | 53 | 0.040 |
Why?
|
Phosphatidylethanolamines | 1 | 2020 | 128 | 0.040 |
Why?
|
Databases, Factual | 3 | 2024 | 8067 | 0.040 |
Why?
|
Caprylates | 1 | 2020 | 114 | 0.040 |
Why?
|
Carbapenems | 1 | 2021 | 125 | 0.040 |
Why?
|
Japan | 1 | 2024 | 1415 | 0.040 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2020 | 168 | 0.040 |
Why?
|
Cephalosporins | 1 | 2020 | 200 | 0.040 |
Why?
|
Health Care Surveys | 1 | 2007 | 2424 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2024 | 1866 | 0.040 |
Why?
|
Macrolides | 1 | 2020 | 204 | 0.040 |
Why?
|
Students, Medical | 1 | 2013 | 1959 | 0.040 |
Why?
|
beta-Lactams | 1 | 2021 | 158 | 0.040 |
Why?
|
Carnitine | 1 | 2020 | 253 | 0.040 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2019 | 72 | 0.040 |
Why?
|
DNA | 4 | 2021 | 7202 | 0.040 |
Why?
|
Azithromycin | 1 | 2020 | 201 | 0.040 |
Why?
|
Nuts | 1 | 2021 | 265 | 0.040 |
Why?
|
beta 2-Glycoprotein I | 1 | 2018 | 27 | 0.040 |
Why?
|
Dilatation, Pathologic | 1 | 2020 | 527 | 0.040 |
Why?
|
beta-Lactamases | 1 | 2021 | 308 | 0.040 |
Why?
|
Adolescent | 4 | 2020 | 88835 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12240 | 0.040 |
Why?
|
Attitude to Health | 1 | 2008 | 2020 | 0.040 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2018 | 32 | 0.040 |
Why?
|
Rheumatoid Factor | 1 | 2019 | 183 | 0.040 |
Why?
|
Caregivers | 2 | 2021 | 2307 | 0.040 |
Why?
|
Tryptophan | 1 | 2020 | 483 | 0.040 |
Why?
|
Fluoroquinolones | 1 | 2020 | 307 | 0.040 |
Why?
|
Asthma | 1 | 2017 | 6270 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2020 | 345 | 0.040 |
Why?
|
Fever of Unknown Origin | 1 | 2018 | 94 | 0.040 |
Why?
|
Child Abuse, Sexual | 1 | 2021 | 397 | 0.040 |
Why?
|
Quarantine | 1 | 2020 | 185 | 0.040 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2018 | 101 | 0.040 |
Why?
|
Hepatitis B Antigens | 1 | 2017 | 38 | 0.040 |
Why?
|
Hip | 1 | 2019 | 249 | 0.040 |
Why?
|
Methionine | 1 | 2020 | 569 | 0.040 |
Why?
|
Leukopenia | 1 | 2018 | 213 | 0.040 |
Why?
|
Raynaud Disease | 1 | 2018 | 81 | 0.040 |
Why?
|
Papillomavirus Infections | 1 | 2010 | 1640 | 0.040 |
Why?
|
Child | 4 | 2021 | 80564 | 0.040 |
Why?
|
Arthritis, Infectious | 1 | 2021 | 345 | 0.040 |
Why?
|
Child, Preschool | 3 | 2021 | 42500 | 0.040 |
Why?
|
Age Factors | 3 | 2021 | 18380 | 0.040 |
Why?
|
Hepatitis C | 1 | 2008 | 1597 | 0.040 |
Why?
|
Penicillins | 1 | 2020 | 404 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2021 | 3800 | 0.030 |
Why?
|
Hepatitis B Antibodies | 1 | 2017 | 156 | 0.030 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2018 | 147 | 0.030 |
Why?
|
Injections | 1 | 2020 | 840 | 0.030 |
Why?
|
North America | 1 | 2020 | 1285 | 0.030 |
Why?
|
Influenza A virus | 1 | 2020 | 453 | 0.030 |
Why?
|
Antiphospholipid Syndrome | 1 | 2018 | 166 | 0.030 |
Why?
|
Drug Substitution | 1 | 2019 | 292 | 0.030 |
Why?
|
Antiviral Agents | 2 | 2020 | 3050 | 0.030 |
Why?
|
Probability | 1 | 2022 | 2475 | 0.030 |
Why?
|
Waist Circumference | 1 | 2020 | 932 | 0.030 |
Why?
|
Autoimmunity | 1 | 2024 | 1354 | 0.030 |
Why?
|
Hepatitis, Autoimmune | 1 | 2018 | 170 | 0.030 |
Why?
|
Adenoviridae | 1 | 2020 | 1092 | 0.030 |
Why?
|
Prosthesis-Related Infections | 1 | 2021 | 496 | 0.030 |
Why?
|
Bone Remodeling | 1 | 2019 | 577 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2024 | 2233 | 0.030 |
Why?
|
History, 20th Century | 1 | 2003 | 2761 | 0.030 |
Why?
|
Administration, Topical | 1 | 2017 | 704 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1659 | 0.030 |
Why?
|
Computer Simulation | 2 | 2019 | 6255 | 0.030 |
Why?
|
Hospitalization | 3 | 2020 | 10808 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1971 | 0.030 |
Why?
|
Scleroderma, Systemic | 1 | 2018 | 346 | 0.030 |
Why?
|
Odds Ratio | 2 | 2020 | 9649 | 0.030 |
Why?
|
Diet, Mediterranean | 1 | 2021 | 746 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12976 | 0.030 |
Why?
|
Regression Analysis | 1 | 2003 | 6322 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2020 | 1426 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2020 | 2721 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2021 | 1424 | 0.030 |
Why?
|
Disease Progression | 2 | 2020 | 13632 | 0.030 |
Why?
|
Deglutition Disorders | 1 | 2018 | 639 | 0.030 |
Why?
|
Spine | 1 | 2019 | 1128 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2017 | 866 | 0.020 |
Why?
|
Pain | 2 | 2017 | 5077 | 0.020 |
Why?
|
Tennessee | 1 | 2012 | 123 | 0.020 |
Why?
|
Weight Loss | 1 | 2003 | 2710 | 0.020 |
Why?
|
Recurrence | 1 | 2024 | 8501 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2020 | 2024 | 0.020 |
Why?
|
Age of Onset | 1 | 2019 | 3344 | 0.020 |
Why?
|
Military Personnel | 1 | 2020 | 1252 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4778 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1808 | 0.020 |
Why?
|
DNA, Viral | 1 | 2017 | 2199 | 0.020 |
Why?
|
Bacteriological Techniques | 1 | 2012 | 276 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2699 | 0.020 |
Why?
|
Fast Foods | 1 | 2013 | 220 | 0.020 |
Why?
|
Public Health | 1 | 2003 | 2680 | 0.020 |
Why?
|
Organizational Policy | 1 | 2013 | 434 | 0.020 |
Why?
|
Fatigue | 1 | 2017 | 1549 | 0.020 |
Why?
|
Lung Diseases, Interstitial | 1 | 2018 | 939 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 4015 | 0.020 |
Why?
|
Prenatal Diagnosis | 2 | 1988 | 1268 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2535 | 0.020 |
Why?
|
Policy Making | 1 | 2013 | 546 | 0.020 |
Why?
|
Nasal Mucosa | 1 | 2012 | 416 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2904 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4255 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2017 | 1873 | 0.020 |
Why?
|
Infant | 1 | 2010 | 36386 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2021 | 3837 | 0.020 |
Why?
|
Critical Illness | 1 | 2020 | 2744 | 0.020 |
Why?
|
Commerce | 1 | 2013 | 611 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8875 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6499 | 0.020 |
Why?
|
AIDS Serodiagnosis | 1 | 2008 | 220 | 0.020 |
Why?
|
Vagina | 1 | 2012 | 848 | 0.020 |
Why?
|
Animals | 1 | 2018 | 168764 | 0.020 |
Why?
|
Muscular Dystrophies | 1 | 1988 | 392 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9591 | 0.020 |
Why?
|
Inflammation | 1 | 2024 | 10850 | 0.010 |
Why?
|
Hemoglobinopathies | 1 | 1984 | 101 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12795 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 4058 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5370 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3413 | 0.010 |
Why?
|
HIV Infections | 1 | 2008 | 17533 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2008 | 2739 | 0.010 |
Why?
|
Fetal Diseases | 1 | 1984 | 914 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 13462 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2012 | 26346 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2008 | 5508 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1988 | 1306 | 0.000 |
Why?
|
Creatine Kinase | 1 | 1988 | 682 | 0.000 |
Why?
|
Chorionic Villi | 1 | 1984 | 53 | 0.000 |
Why?
|
X Chromosome | 1 | 1988 | 819 | 0.000 |
Why?
|
Thalassemia | 1 | 1984 | 267 | 0.000 |
Why?
|
Chromosome Deletion | 1 | 1988 | 1385 | 0.000 |
Why?
|
Blood Specimen Collection | 1 | 1984 | 238 | 0.000 |
Why?
|
Genetic Linkage | 1 | 1988 | 2341 | 0.000 |
Why?
|
Genetic Markers | 1 | 1988 | 2601 | 0.000 |
Why?
|
Pregnancy Trimester, Second | 1 | 1984 | 737 | 0.000 |
Why?
|
Pedigree | 1 | 1988 | 4526 | 0.000 |
Why?
|
Pregnancy Trimester, First | 1 | 1984 | 919 | 0.000 |
Why?
|
Polymorphism, Genetic | 1 | 1988 | 4247 | 0.000 |
Why?
|
Chromosome Mapping | 1 | 1984 | 4618 | 0.000 |
Why?
|
Mutation | 2 | 1988 | 30198 | 0.000 |
Why?
|